EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

27.60p
   
  • Change Today:
      0.80p
  • 52 Week High: 37.00
  • 52 Week Low: 24.70
  • Currency: UK Pounds
  • Shares Issued: 453.73m
  • Volume: 603,915
  • Market Cap: £125.23m

EKF Diagnostics making 'good' investment progress

By Josh White

Date: Wednesday 18 May 2022

LONDON (ShareCast) - (Sharecast News) - EKF Diagnostics said in an update on Wednesday that it has already made "good progress" with its investment plans to support growth in the new financial year.
The AIM-traded firm, which was holding its annual general meeting, said it had made "significant" investment to expand its fermentation capabilities at the South Bend, Indiana life sciences facility.

Non-executive chairman Christopher Mills told shareholders the company had a demand-driven pipeline of opportunities that was expected to start flowing once the investment in new fermenters was completed by the end of the current year, with the company on track to have the capacity to support "significant" revenue growth through to 2024.

"We are also making good progress in redeploying our contract manufacturing and laboratory services capacity and skill set into non-Covid related areas," Mills said.

"In contract manufacturing we are actively working with new partners to build a strong pipeline for non-Covid products.

"This includes delivering validation batches for products which are expected to be launched throughout 2022 and into 2023."

Christopher Mills said that in laboratory services, the ADL Health team was expanding its range of testing capabilities across a "broader suite" of healthcare applications, and was progressing well.

"Trading in the first quarter has been strong and we have delivered first quarter revenues in line with that of the corresponding period in 2021, and we remain on track to deliver full-year results in line with current market forecasts.

"In our established point-of-care and central laboratory businesses we continue to see market growth following the Covid slowdown and in the first quarter have seen sales growth compared with 2021.

"As a board we remain confident in delivering on our growth strategy to 2024 and I would like to thank my fellow shareholders for their support."

At 1432 BST, shares in EKF Diagnostics Holdings were down 0.29% at 34.5p.

Reporting by Josh White at Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 27.60p
Change Today 0.80p
% Change 2.99 %
52 Week High 37.00
52 Week Low 24.70
Volume 603,915
Shares Issued 453.73m
Market Cap £125.23m

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.16% below the market average70.16% below the market average70.16% below the market average70.16% below the market average70.16% below the market average
84.76% below the sector average84.76% below the sector average84.76% below the sector average84.76% below the sector average84.76% below the sector average
Price Trend
2.4% below the market average2.4% below the market average2.4% below the market average2.4% below the market average2.4% below the market average
5.17% below the sector average5.17% below the sector average5.17% below the sector average5.17% below the sector average5.17% below the sector average
Income
20.45% above the market average20.45% above the market average20.45% above the market average20.45% above the market average20.45% above the market average
69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average69.7% below the sector average
Growth
67.38% below the market average67.38% below the market average67.38% below the market average67.38% below the market average67.38% below the market average
55.14% below the sector average55.14% below the sector average55.14% below the sector average55.14% below the sector average55.14% below the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 2
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 66 @ 27.60p
16:35 66 @ 27.60p
15:30 190,600 @ 27.20p
15:33 25,000 @ 27.65p
15:08 57 @ 27.65p

EKF Key Personnel

CFO Stephen (Steve) Young

Top of Page